Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherrie L Kelly

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2015
HIV Cascade Monitoring and Simple Modeling Reveal Potential for Reductions in HIV IncidenceSherrie L Kelly, David P Wilson
JMIR Medical Education|April 28, 2026
Bridging the Implementation Gap in Medical AI Education: 3-Lever Framework for Concurrent ReformSherrie L Kelly, Melissa Forgie, Mark C Walker
The International Journal on Drug Policy|November 25, 2016
Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugsClemens Benedikt, Sherrie L Kelly, David Wilson, et al.
AIDS (London, England)|January 31, 2020
Potential health gains in West and Central Africa through savings from lower cost HIV treatmentRobyn M Stuart, Sherrie L Kelly, Rowan Martin-Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2017
Achieving 90-90-90 Human Immunodeficiency Virus (HIV) Targets Will Not Be Enough to Achieve the HIV Incidence Reduction Target in AustraliaNick Scott, Mark Stoové, Sherrie L Kelly, et al.
The Lancet. Microbe|July 12, 2024
Seasonal malaria chemoprevention and the spread of Plasmodium falciparum quintuple-mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling studyThiery Masserey, Tamsin Lee, Sherrie L Kelly, et al.
Malaria Journal|March 14, 2026
Timing of the fourth dose of RTS,S/AS01 malaria vaccine in perennial settings: a modelling studyDaniella Figueroa-Downing, Sherrie L Kelly, Aurélien Cavelan, et al.
Infectious Diseases and Therapy|September 12, 2022
COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target GroupsSherrie L Kelly, Epke A Le Rutte, Maximilian Richter, et al.
Communications Medicine|July 28, 2022
Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burdenEpke A Le Rutte, Andrew J Shattock, Nakul Chitnis, et al.
Communications Medicine|March 25, 2023
Modelling to inform next-generation medical interventions for malaria prevention and treatmentNarimane Nekkab, Josephine Malinga, Lydia Braunack-Mayer, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2015
HIV Cascade Monitoring and Simple Modeling Reveal Potential for Reductions in HIV IncidenceSherrie L Kelly, David P Wilson
JMIR Medical Education|April 28, 2026
Bridging the Implementation Gap in Medical AI Education: 3-Lever Framework for Concurrent ReformSherrie L Kelly, Melissa Forgie, Mark C Walker
The International Journal on Drug Policy|November 25, 2016
Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugsClemens Benedikt, Sherrie L Kelly, David Wilson, et al.
AIDS (London, England)|January 31, 2020
Potential health gains in West and Central Africa through savings from lower cost HIV treatmentRobyn M Stuart, Sherrie L Kelly, Rowan Martin-Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2017
Achieving 90-90-90 Human Immunodeficiency Virus (HIV) Targets Will Not Be Enough to Achieve the HIV Incidence Reduction Target in AustraliaNick Scott, Mark Stoové, Sherrie L Kelly, et al.
The Lancet. Microbe|July 12, 2024
Seasonal malaria chemoprevention and the spread of Plasmodium falciparum quintuple-mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling studyThiery Masserey, Tamsin Lee, Sherrie L Kelly, et al.
Malaria Journal|March 14, 2026
Timing of the fourth dose of RTS,S/AS01 malaria vaccine in perennial settings: a modelling studyDaniella Figueroa-Downing, Sherrie L Kelly, Aurélien Cavelan, et al.
Infectious Diseases and Therapy|September 12, 2022
COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target GroupsSherrie L Kelly, Epke A Le Rutte, Maximilian Richter, et al.
Communications Medicine|July 28, 2022
Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burdenEpke A Le Rutte, Andrew J Shattock, Nakul Chitnis, et al.
Communications Medicine|March 25, 2023
Modelling to inform next-generation medical interventions for malaria prevention and treatmentNarimane Nekkab, Josephine Malinga, Lydia Braunack-Mayer, et al.
Pageof 5